Overview
Sara Erridge practices in Edinburgh, United Kingdom. Ms. Erridge is rated as a Distinguished expert by MediFind in the treatment of Glioblastoma. Her top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri.
Her clinical research consists of co-authoring 36 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 12 articles and participated in 2 clinical trials in the study of Glioblastoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AstrocytomaMs. Erridge isDistinguished. Learn about Astrocytoma.
- GlioblastomaMs. Erridge isDistinguished. Learn about Glioblastoma.
- Advanced
- Brain TumorMs. Erridge isAdvanced. Learn about Brain Tumor.
- GliomaMs. Erridge isAdvanced. Learn about Glioma.
- Gliomatosis CerebriMs. Erridge isAdvanced. Learn about Gliomatosis Cerebri.
- Experienced
- Cerebral HypoxiaMs. Erridge isExperienced. Learn about Cerebral Hypoxia.
- MeningiomaMs. Erridge isExperienced. Learn about Meningioma.
- Metastatic Brain TumorMs. Erridge isExperienced. Learn about Metastatic Brain Tumor.
- Neurofibromatosis Type 2 (NF2)Ms. Erridge isExperienced. Learn about Neurofibromatosis Type 2 (NF2).